Profil
Mr. Kenji Kakuta is a Principal at MVC Corp.
He joined MVC Corporation in January 2009.
He had worked for Nikko antfactory K.K.
(currently known as “ant Capital Partners Co., Ltd.”) from 2005 to 2008, investing mainly in biotech and healthcare ventures.
In total, he had invested around $40MM in 24 companies, three of which have successfully completed IPO so far.
He started his professional career in 2002 at Product Marketing, R&D division of Proctor & Gamble Far East Inc. (currently known as “Procter & Gamble Japan K.K.”).
He has the master's degree in Agricultural Science from Kyoto University, and the bachelor's degree in Agricultural Science from Kyoto University.
Aktive Positionen von Kenji Kakuta
| Unternehmen | Position | Beginn |
|---|---|---|
Mitsui & Co. Global Investment Ltd.
 Mitsui & Co. Global Investment Ltd. Investment ManagersFinance Mitsui & Co. Global Investment Ltd is a private Equity/venture Capital firm, a subsidiary of Mitsui & Co., Ltd. founded in 1996. The firm is headquartered in Tokyo. | Private Equity Investor | 26.07.2010 |
iHeart Japan Corp.
 iHeart Japan Corp. Medical/Nursing ServicesHealth Services iHeart Japan Corp. operates as a medical research and development firm. It develops therapies that can replace heart transplantation for severe heart failure. The firm applies the iPS cell research and application technology for its therapies. The company was founded by Jun Yamashita on April 18, 2013 and is headquartered in Kyoto, Japan. | Gründer | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Mitsui & Co. Global Investment Ltd.
Mitsui & Co. Global Investment Ltd. Investment ManagersFinance Mitsui & Co. Global Investment Ltd is a private Equity/venture Capital firm, a subsidiary of Mitsui & Co., Ltd. founded in 1996. The firm is headquartered in Tokyo. | Finance |
iHeart Japan Corp.
iHeart Japan Corp. Medical/Nursing ServicesHealth Services iHeart Japan Corp. operates as a medical research and development firm. It develops therapies that can replace heart transplantation for severe heart failure. The firm applies the iPS cell research and application technology for its therapies. The company was founded by Jun Yamashita on April 18, 2013 and is headquartered in Kyoto, Japan. | Health Services |